How severe is CVE-2024-6523?

CVE-2024-6523 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-6523 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-6523?

CVE-2024-6523 affects Zkteco Biotime. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-6523?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-6523 have an EU (EUVD) identifier?

Yes. CVE-2024-6523 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-47604.

When was CVE-2024-6523 published?

CVE-2024-6523 was published on 2024-07-05 and last updated on 2026-06-17.

CVE-2024-6523

CVE-2024-6523 is a low-severity vulnerability in Zkteco Biotime with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Low (CVSS 3.x base score 3.5)
CVSS v2: 4.0
CVSS v4: 5.3
EPSS exploit prediction: 0% (38th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-47604
Weakness: CWE-79
Affected product: Zkteco Biotime
Published: 2024-07-05
Last modified: 2026-06-17

Description

A vulnerability was found in ZKTeco BioTime up to 9.5.2. It has been classified as problematic. Affected is an unknown function of the component system-group-add Handler. The manipulation of the argument user with the input <script>alert('XSS')</script> leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. VDB-270366 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Frequently asked questions

What is CVE-2024-6523?: A vulnerability was found in ZKTeco BioTime up to 9.5.2. It has been classified as problematic. Affected is an unknown function of the component system-group-add Handler. The manipulation of the argument user with the input <script>alert('XSS')</script> leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. VDB-270366 is the identifier assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
How severe is CVE-2024-6523?: CVE-2024-6523 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-6523 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-6523?: CVE-2024-6523 affects Zkteco Biotime. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-6523?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-6523 have an EU (EUVD) identifier?: Yes. CVE-2024-6523 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-47604.
When was CVE-2024-6523 published?: CVE-2024-6523 was published on 2024-07-05 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:zkteco:biotime:*:*:*:*:*:*:*:*

More vulnerabilities in Zkteco Biotime

CVE-2023-38951 — Critical (CVSS 9.8): ZKTeco BioTime 8.5.5 through 9.x before 9.0.1 (20240617.19506) allows authenticated attackers to create or overwrite…
CVE-2023-51142 — High (CVSS 7.5): An issue in ZKTeco BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information.
CVE-2023-38952 — High (CVSS 7.5): Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due…
CVE-2023-38950 — High (CVSS 7.5): A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read…
CVE-2023-38949 — High (CVSS 7.5): An issue in a hidden API in ZKTeco BioTime v8.5.5 allows unauthenticated attackers to arbitrarily reset the…
CVE-2024-13966 — High (CVSS 7.3): ZKTeco BioTime allows unauthenticated attackers to enumerate usernames and log in as any user with a password unchanged…

All CVEs affecting Zkteco Biotime →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →